Navigation Links
Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study

RICHMOND, Va.--(BUSINESS WIRE)--Apr 30, 2007 - Insmed Inc., (Nasdaq:INSM) today announced positive results from a Phase II investigator-sponsored clinical study of the company's drug IPLEX(TM) in HIV-infected patients affected with HIV-associated Adipose Redistribution Syndrome (HARS).

Preliminary results from the study, being conducted at the University of California, San Francisco, showed that three months of 0.5 mg/kg/day IPLEX treatment in seven patients increased IGF-I levels 3-fold and was associated with significant improvements in fasting glucose levels, the amount of insulin secreted during an oral glucose tolerance test, and overall insulin sensitivity. Moreover, there was a significant reduction in trunk fat and a positive downward trend in waist circumference when compared to baseline. Lipid profiles also tended to improve.

Notably, normal glucose tolerance was restored in half of the six patients diagnosed with impaired glucose tolerance (IGT) at the start of the study. These IGT patients also experienced a significant decrease in visceral adipose tissue (VAT). Impaired glucose tolerance is characterized by blood glucose between 140 and 200 mg/dl at the 120-minute measurement of an oral glucose tolerance test. The next phase of the study is underway to explore an IPLEX dose of 1.0 mg/kg/day given for six months.

"Our study has demonstrated that a low dose of IPLEX increased IGF-I levels 3-fold and positively impacted abnormal glucose metabolism, dyslipdemia and abnormal fat distribution, which are present in a significant number of HIV patients treated with highly active antiretroviral therapy (HAART)," said Morris Schambelan, M.D., the study's principal investigator and professor of medicine and director of the General Clinical Research Centers at University of California, San Francisco, and chief of endocrinology at San Francisco General Hospital.

"We are very encouraged by t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference
2. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
3. Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study
4. State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... the "Global Biobanking Market 2015-2019" report to ... Biobanking market to grow at a CAGR of 7.07% ... market can be divided into two segments: Equipment and ... growth prospects of the Global Biobanking market for the ...
(Date:4/24/2015)... Hi-Tech Pharmaceuticals refutes the results from ... of reliable scientific principles and methods and therefore ... of adulteration. The FDA is resting its very, ... misguided hope, that Methylphenylethylamine is not found in ... multiple other studies and cannot be relied on ...
Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries ... Best Implementation Award. This award is given to ... of RFID technology to improve its manufacturing, supply chain ... best demonstrates how RFID is delivering real value to ... Live! 2015 in San Diego, the RFID industries annual ...
(Date:4/24/2015)... Illinois (PRWEB) April 24, 2015 Multi ... includes septic tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 ... to start the program. This does not include any ... applicable. Save $25-$65 per person. If someone is part ... or two tanks totaling approximately 2500 gallons or more, ...
(Date:4/24/2015)... The Fastest Fat Loss Week Ever, released by Shaun Hadsall ... Fat Loss Diet, has been causing a lot of commotion ... to help one lose belly fat in only 25 days ... investigative review. , "Our Fastest Fat Loss Week Ever ... experimenting with these methods on their clients with great success. ...
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
(Date:4/24/2015)... April 24, 2015 Integrative Therapeutics ... key pathways: immunity and cognition. , A unique ... helps set ProThrivers™ Wellness Flavonoid Complex apart from ... combination of ingredients to support antioxidation versus the ... unites curcumin, green tea extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, ...
Breaking Medicine News(10 mins):Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4
... The Female Health Company,(Amex: FHC ) announced ... which,implements the USAID | DELIVER PROJECT, for the delivery ... Agency for International,Development (USAID) programs., For many years, ... and condoms. The Agency developed an operational plan for,its ...
... mice show curcumin reduces heart enlargement and lowers odds ... -- Curcumin, an ingredient in the curry spice tumeric, ... of heart failure, Canadian researchers say. , The scientists ... General Hospital tested the effects of curcumin in mice ...
... carries same risk as other circulatory problems, experts say. ... suffering from age-related macular degeneration (AMD) have twice the ... researchers report. , The degenerative eye disease is the ... in developed countries and affects the center of the ...
... Inc. (Nasdaq: NHWK ), the leading provider of ... States,today announced that it will present at the Cowen ... 18, 2008, at 11:00 am EDT at the,Boston Marriott ... and,Chief Executive Officer, Andrea Clegg, Vice President of Finance ...
... TORONTO, Feb. 28 /PRNewswire-FirstCall/ - MDS Inc. (TSX: ... services to the global life,sciences markets, announced that ... on Thursday, March 6., The Company will ... P.,DeFalco, President and Chief Executive Officer and Douglas ...
... clubs across the country will become the "Gateway to,Healthy ... transform,their lives and take better care of themselves., ... Annual,Get Active America! program, participating health clubs will open ... can revitalize their lives and,benefit from the supportive environment ...
Cached Medicine News:Health News:The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units 2Health News:Curry Ingredient May Cut Cardiovascular Risks 2Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 2Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 3Health News:NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 3
... a scientifically advanced nutritional formulation that ... full body health. MacularProtect Complete is ... and other advanced research. It features ... a broad foundation of antioxidants, such ...
... is a scientifically advanced multinutrient ... visual and full body health. ... nutrients, including a diverse array ... lutein, lycopene and OptiBerry and ...
Ocuvite® Lutein is an advanced antioxidant supplement formulated to provide nutritional support for the eye....
... The herbal extracts, vitamins, ... formula increases circulation to ocular ... maintains healthy function of the ... eye. This formula is optimized ...
Medicine Products: